ロード中...
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
The administration of mesenchymal stem cells (MSCs) as a therapy for liver disease holds great promise. MSCs can differentiate into hepatocytes, reduce liver inflammation, promote hepatic regeneration and secrete protective cytokines. However, the risks of iatrogenic tumor formation, cellular reject...
保存先:
| 出版年: | Exp Mol Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5519012/ https://ncbi.nlm.nih.gov/pubmed/28620221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.63 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
ロード中...